Clinical profiling, treatment characteristics and outcome in Behcet's Disease (BD)-A retrospective cohort study from Karnataka Rheumatology Association (KRA)

被引:0
作者
Rao, Vijay K. [1 ]
Kodali, Ramya Sri [2 ]
Patil, Abhishek [3 ]
Chebbi, Pramod [4 ]
Subramanian, R. [5 ]
Kumar, Sharath [6 ]
Singh, Yogesh Preet [7 ]
Chandrashekara, S. [8 ]
Shobha, Vineeta [2 ]
机构
[1] Divisha Arthrit & Med Ctr, Bangalore, India
[2] St Johns Med Coll Hosp, Dept Clin Immunol & Rheumatol, Sarjapur Rd, Bengaluru 560034, India
[3] Manipal Hosp, Dept Rheumatol, Bengaluru, India
[4] SDM Coll Med Sci & Hosp, Dharwad, India
[5] JSS Acad Higher Educ & Res, JSS Med Coll, Mysore, India
[6] OPTIMA Rheumatol Hosp, Bengaluru, India
[7] All India Inst Med Sci, Bilaspur, India
[8] ChanRe Rheumatol & Immunol Ctr & Res, Bengaluru, India
关键词
Behcet's disease; Clinical phenotype; Outcome; Pathergy; Prescription pattern; HLA ANTIGENS; INDIA; MANAGEMENT;
D O I
10.1007/s10067-024-07089-x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BackgroundBehcet's disease (BD) has a heterogeneous and unpredictable phenotype that differs in various geographical areas.ObjectiveTo describe the clinical phenotype & outcome of Behcet's disease(BD) from Karnataka, India and compare them with large cohorts from endemic regions.MethodsDatabases of practising rheumatologists from Karnataka were reviewed to retrieve clinical characteristics, course of illness, prescribing information and outcome at last follow-up of patients clinically diagnosed as BD. The classification criteria, namely revised International criteria for Behcet's disease (rICBD) and International study group (ISG) criteria were applied. Outcome was defined as complete or partial remission, persistent disease or relapse.ResultsWe included 72 patients, equal gender distribution and mean age 37.4 +/- 12.8 years from 8 rheumatology centres. Commonest presentations were recurrent oral aphthosis 58(80.6%), genital ulcers 36(50%) and ocular manifestations 40(55.6%). Three-quarters [51/72(70.8%)] fulfilled rICBD criteria whereas only half [36/72(50%)] fulfilled ISG criteria. Apart from glucocorticoids [53/72(73.6%)], frequently prescribed therapies were colchicine 39(54.2%) and azathioprine 35(48.6%). Eleven-patients received biologics(anti-TNF-alpha) and JAK inhibitors to treat severe organ involvement. HLA-B*51 and pathergy tests were positive in 27/45(60%) and 12/34(35.3%) patients respectively. Outcomes were documented in 94.4%(68/72) patients at median follow-up of 24 (12;36) months. Majority [46/68(67.6%)] had complete remission, 17/68(25%) had partial remission, 4/68(5.9%) had persistent while 1/68(1.5%) had relapsing course.ConclusionMajority of BD patients had orogenital aphthosis and ocular manifestations and an excellent response to treatment. Key Points center dot In our region, Beh & ccedil;et's Disease primarily manifests with recurrent oral aphthae and ocular involvement, with comparatively lower incidence of severe genital ulcers and neurological involvement than in endemic regions.center dot Apart from glucocorticoids, colchicine and azathioprine are the most commonly used agents. Biologics and JAK inhibitors are prescribed infrequently, primarily in cases of severe organ involvement.center dot A significant proportion of patients achieved either complete or partial remission during follow-up, with no observed mortality suggesting a milder disease course and better outcome compared to endemic regions.center dot Gender, HLA-B*51 status, and pathergy response did not exert any significant influence on the clinical profile or outcome in BD patients in Karnataka.
引用
收藏
页码:3223 / 3230
页数:8
相关论文
共 27 条
  • [1] Alekberova ZS, 2008, TERAPEVT ARKH, V80, P56
  • [2] ALTAC M, 1982, ACTA DERM-VENEREOL, V62, P158
  • [3] Bang D, 2003, ADV EXP MED BIOL, V528, P59
  • [4] The comparison between Behcet's disease and spondyloarthritides: Does Behcet's disease belong to the spondyloarthropathy complex?
    Chang, HK
    Lee, DH
    Jung, SM
    Choi, SJ
    Kim, JU
    Choi, YJ
    Baek, SK
    Cheon, KS
    Cho, EH
    Won, KS
    [J]. JOURNAL OF KOREAN MEDICAL SCIENCE, 2002, 17 (04) : 524 - 529
  • [5] Epidemiological, clinical, and therapeutic characteristics of Behcet's disease: a monocentric study in Tunisia
    Daoud, Fatma
    Rachdi, Imene
    Somai, Mehdi
    Zaouak, Anissa
    Hammami, Houda
    Ouederni, Meriem
    Maamouri, Rym
    Zoubeidi, Hana
    Tougorti, Molka
    Ksouri, Jihene
    Ben Dhaou, Besma
    Aydi, Zohra
    Fenniche, Samy
    Cheour, Monia
    Boussema, Fatma
    [J]. PAN AFRICAN MEDICAL JOURNAL, 2021, 40
  • [6] The International Criteria for Behcet's Disease (ICBD): a collaborative study of 27 countries on the sensitivity and specificity of the new criteria
    Davatchi, F.
    Assaad-Khalil, S.
    Calamia, K. T.
    Crook, J. E.
    Sadeghi-Abdollahi, B.
    Schirmer, M.
    Tzellos, T.
    Zouboulis, C. C.
    Akhlagi, M.
    Al-Dalaan, A.
    Alekberova, Z. S.
    Ali, A. A.
    Altenburg, A.
    Arromdee, E.
    Baltaci, M.
    Bastos, M.
    Benamour, S.
    Ben Ghorbel, I.
    Boyvat, A.
    Carvalho, L.
    Chen, W.
    Ben-Chetrit, E.
    Chams-Davatchi, C.
    Correia, J. A.
    Crespo, J.
    Dias, C.
    Dong, Y.
    Paixao-Duarte, F.
    Elmuntaser, K.
    Elonakov, A. V.
    Grana Gil, J.
    Haghdoost, A-A.
    Hayani, R. M.
    Houman, H.
    Isayeva, A. R.
    Jamshidi, A. R.
    Kaklamanis, P.
    Kumar, A.
    Kyrgidis, A.
    Madanat, W.
    Nadji, A.
    Namba, K.
    Ohno, S.
    Olivieri, I.
    Vaz Patto, J.
    Pipitone, N.
    de Queiroz, M. V.
    Ramos, F.
    Resende, C.
    Rosa, C. M.
    [J]. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2014, 28 (03) : 338 - 347
  • [7] Adult Behcet's disease in Iran: analysis of 6075 patients
    Davatchi, Fereydoun
    Chams-Davatchi, Cheyda
    Shams, Hormoz
    Nadji, Abdolhadi
    Faezi, Tahereh
    Akhlaghi, Massoomeh
    Sadeghi Abdollahi, Bahar
    Ashofteh, Farimah
    Ghodsi, Zahra
    Mohtasham, Negin
    Shahram, Farhad
    [J]. INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2016, 19 (01) : 95 - 103
  • [8] Diagnostic value of pathergy test in Behcet's disease according to the change of incidence over the time
    Davatchi, Fereydoun
    Chams-Davatchi, Cheyda
    Ghodsi, Zahra
    Shahram, Farhad
    Nadji, Abdolhadi
    Shams, Hormoz
    Akhlaghi, Massoomeh
    Larimi, Roghieh
    Sadeghi-Abdolahi, Bahar
    [J]. CLINICAL RHEUMATOLOGY, 2011, 30 (09) : 1151 - 1155
  • [9] Behcet's disease: from east to west
    Davatchi, Fereydoun
    Shahram, Farhad
    Chams-Davatchi, Cheyda
    Shams, Hormoz
    Nadji, Abdolhadi
    Akhlaghi, Massoomeh
    Faezi, Tahereh
    Ghodsi, Zahra
    Faridar, Alireza
    Ashofteh, Farima
    Abdollahi, Bahar Sadeghi
    [J]. CLINICAL RHEUMATOLOGY, 2010, 29 (08) : 823 - 833
  • [10] HLA-B51/B5 and the Risk of Behcet's Disease: A Systematic Review and Meta-Analysis of Case-Control Genetic Association Studies
    de Menthon, Mathilde
    LaValley, Michael P.
    Maldini, Carla
    Guillevin, Loic
    Mahr, Alfred
    [J]. ARTHRITIS CARE & RESEARCH, 2009, 61 (10) : 1287 - 1296